Monash University and Corvus Pharmaceuticals enter into exclusive license agreement for Novel Immuno-Oncology Program
Monash University and Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, have announced today they have entered into an exclusive agreement. Under the agreement, Corvus has licensed global rights to anMedicine & health
Monash University’s Biomedicine Discovery Institute researchers have led an international study that found – for the first time – that a diet yielding high amounts of the short-chain fatty acids acetate and butyrate provided a beneficialMedicine & health
A National Institutes of Health grant will allow Monash University biomedical scientist Dr Di Yu to contribute to the search for an HIV cure. Dr Yu, from the School of...